On Wednesday, Boston Scientific Corporation (NYSE:BSX)’s shares declined -0.05% to $18.67.
BSX has market value of $25.09 billion while its EPS was booked as $-0.30 in the last 12 months. The stock has 1.34 billion shares outstanding while 91.90% shares of the company were owned by institutional investors. In the profitability analysis, the company has gross profit margin of 71.20% while net profit margin was -5.40%. Beta value of the company was 1.04; beta is used to measure riskiness of the security.
The mean estimate for the short term price target for Boston Scientific Corporation (NYSE:BSX) stands at $20.76 according to 23 Analysts. The higher price target estimate for the stock has been calculated at $23.00 while the lower price target estimate is at $19.00.
Analysts mean recommendation for the stock is 1.90. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses.
Endo International plc - Ordinary Shares (NASDAQ:ENDP)’s shares dropped -1.26% to $60.49.
ENDP is currently valued at $13.87 billion. The company has 226.40 million shares outstanding and 99.90% shares of the company were owned by institutional investors. The company has 4.54 value in price to sale ratio while price to book ratio was recorded as 1.82. The company exchanged hands with 3.54 million shares as compared to its average daily volume of 5.84 million shares. It beta stands at 1.15.
The mean estimate for the short term price target for Endo International plc - Ordinary Shares (NASDAQ:ENDP) stands at $92.47 according to 17 Analysts. The higher price target estimate for the stock has been calculated at $115.00 while the lower price target estimate is at $70.00.
Analysts mean recommendation for the stock is 2.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals.
At the end of Wednesday’s trade, Tenet Healthcare Corp (NYSE:THC)‘s shares dipped -0.18% to $34.20.
THC has beta value of 1.77. The company has the market capitalization of $3.41 billion. Return on assets ratio of the company was 0.30% while its return on equity ratio was 7.30%. ATR value of company was 2.11 while stock volatility for week was 5.62% while for month was 5.87%. Debt to equity ratio of the company was -18.37 and its current ratio was 1.60.
The mean estimate for the short term price target for Tenet Healthcare Corp (NYSE:THC) stands at $48.39 according to 18 Analysts. The higher price target estimate for the stock has been calculated at $85.00 while the lower price target estimate is at $30.00.
Analysts mean recommendation for the stock is 2.30. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Tenet Healthcare Corporation is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery netoperates in large urban and suburban markets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.